Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases

AIM: To assess clinical and endoscopic response to propionyl-L-carnitine hydrochloride (PLC) in colonic inflammatory bowel disease. METHODS: Patients suffering from mild to moderate ulcerative colitis (UC) or Crohn’s disease (CD) colitis, with disease activity index (DAI) between 3 and 10 and under...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Merra, Giuseppe, Gasbarrini, Giovanni, Laterza, Lucrezia, Pizzoferrato, Marco, Poscia, Andrea, Scaldaferri, Franco, Arena, Vincenzo, Fiore, Francesca, Cittadini, Achille, Sgambato, Alessandro, Franceschi, Francesco, Gasbarrini, Antonio
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Baishideng Publishing Group Co., Limited 2012
Pynciau:
Brief Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3460333/
https://ncbi.nlm.nih.gov/pubmed/23049215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v18.i36.5065
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg